Niramaya PathLabs
Niramaya PathLabs is an NABL-accredited pathology and wellness provider in Delhi NCR, offering individual diagnostic tests, preventive health packages, home sample collection, COVID-19 RT-PCR, and corporate health check-ups to individual patients and 50+ enterprise clients across India.
- Company typePrivate
- Founded2015
- HeadquartersNew Delhi, India
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Niramaya PathLabs does
Niramaya PathLabs (legal entity NirAmaya PathLabs Private Limited) is an NABL-accredited, ICMR-approved pathology and wellness service provider headquartered in New Delhi, operating primarily in the National Capital Region of India. The company runs a central reference laboratory and a network of Patient Care Centres (PCCs) across Delhi, Gurugram, Noida, Ghaziabad, Faridabad, Greater Noida, and Indirapuram, supplemented by home sample collection services within serviceable NCR pin codes (and selectively in Bangalore). Its test portfolio spans routine biochemistry, hematology, immunology, microbiology, histopathology, molecular diagnostics (including India's first IVD-approved automated DNA/RNA extraction on Qiagen Qia-Symphony), fully automated flow cytometry, hemoglobin/protein electrophoresis, ELISA, and SARS-CoV-2 RT-PCR, supported by an integrated IT lab management platform for report delivery to clinicians and franchisees.
The company's revenue model is built on small-ticket individual pathology tests and bundled health check-up packages sold direct-to-consumer via its website, phone helpline, and walk-in PCCs, with pricing typically ranging from ₹100-₹1,500 per test and packages up to ₹2,999. It also generates B2B revenue from corporate employee health check-up programs, on-site camps, pre-policy medical evaluations for insurance companies and TPAs, virtual doctor consultations, and franchise/Patient Care Centre operations, with a stated base of 50+ corporate clients across technology, logistics, automotive, finance, hospitality, and healthcare industries. Niramaya PathLabs operates as a unit of Anshu Hospitals Limited, a 33+ year hospital group, and its subsidiary ecosystem includes the National Reference Laboratory, multiple Niramaya Hospitals and Health Clinics, a Dialysis Centre, and an Imaging Centre operated in partnership with NDMC.
Niramaya PathLabs firmographics
Firmographics- Name
- Niramaya PathLabs
- Legal name
- NirAmaya PathLabs Private Limited
- Website
- https://niramayahealthcare.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Niramaya PathLabs is an NABL-accredited pathology and wellness provider in Delhi NCR, offering individual diagnostic tests, preventive health packages, home sample collection, COVID-19 RT-PCR, and corporate health check-ups to individual patients and 50+ enterprise clients across India.
- Ownership category
- akta.pro rank
Niramaya PathLabs industry classification
Industry- Product category
- Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)
- akta.pro secondary industries
- Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD), Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN), Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI)
Keywords
Where Niramaya PathLabs is headquartered
LocationHeadquarters
- HQ city
- New Delhi
- HQ country
- India
- HQ region
- Asia
Offices11 records
Markets served
Niramaya PathLabs business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Individual Diagnostic Tests and Profiles: Revenue generated from individual pathology tests (e.g., Blood Sugar Fasting at ₹100, Triglycerides at ₹300) and test profiles/packages sold directly to consumers via website or at PCC centers. Tests range from routine chemistry to specialized molecular diagnostics. Payment is made at point of booking or at sample collection.
- Health Check-up Packages: Preventive health check-up packages sold to individuals, including Basic Health Checkup (₹999), Complete Health Checkup (₹1,399), Male Health Package (₹2,999), and specialized packages for kids and teenagers. These packages bundle multiple tests at discounted rates compared to individual pricing.
- Corporate Health Check-up Services: B2B revenue from employee health check-up programs, corporate medical room management, pre-employment medical examinations, and pre-policy medical evaluations for insurance companies. Services are tailored for corporate clients and TPAs.
- Home Sample Collection Services: Fees charged for home sample collection services (₹250 for phlebotomy within serviceable areas, ₹2,000 for non-serviceable areas), including logistics and phlebotomy. Additional charges apply based on distance and number of tests.
- COVID-19 Testing and Related Services: Revenue from COVID-19 RT-PCR testing (₹700 standard, ₹1,400 urgent 8-hour) and antibody tests. Also includes COVID immunity and bio-marker assessment packages ranging from ₹1,499 to ₹2,999.
- Virtual Doctor Consultations: Tele-consultation services with general physicians (₹500) and specialists (₹800), providing virtual medical consultations bundled with diagnostic services.
- Franchise / Patient Care Center Operations: Revenue derived from operating and supporting a network of Patient Care Centers (PCC) across NCR, including franchise-style centers in locations such as Crossing Republik, Ghaziabad. Centers offer full phlebotomy and sample collection services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Individual Diagnostic Tests - Unit Pricing |
| Unit Pricing | Pay-as-you-go | Preventive Health Check-up Packages |
| Unit Pricing | Pay-as-you-go | COVID-19 Special Packages |
| Unit Pricing | Pay-as-you-go | Home Sample Collection Services |
| Unit Pricing | Pay-as-you-go | Virtual Consultations |
| Unit Pricing | Pay-as-you-go | Phlebo and On-site Services |
| Other | Pay-as-you-go | Online Booking Discount |
Go-to-market motion2 records
Distribution channels6 records
Marketing channels7 records
Niramaya PathLabs product offering
Product offeringCore offering
Niramaya PathLabs operates a NABL-accredited pathology and wellness diagnostic laboratory offering individual blood, urine and culture tests, bundled test profiles, preventive health check-up packages, COVID-19 RT-PCR and antibody testing, home sample collection across Delhi NCR, and corporate employee health check-up programs. The company's services are delivered through a central lab in New Delhi, a network of Patient Care Centres across NCR, and a phlebotomy team that performs doorstep sample collection. It also runs a National Reference Laboratory equipped with advanced molecular diagnostics, flow cytometry, and histopathology platforms.
Product overview
Niramaya PathLabs is a pathology and wellness service provider offering a comprehensive diagnostic portfolio consisting of individual laboratory tests (blood, urine, cultures, cancer markers, hormones), bundled test profiles (CBC, LFT, lipid profiles), preventive health checkup packages (Basic, Complete, Male, Female, Kids), COVID-19 testing services (RT-PCR, antibody tests), home sample collection services, patient care services, and corporate health solutions. The company operates a National Reference Laboratory with advanced genetic and molecular diagnostics capabilities. Services are accessible through patient care centers across Delhi NCR with online booking and report delivery.
Differentiator
Problem solved
Functional benefit
Products and services
- Individual Pathology Tests Catalog of standalone pathology tests such as Blood Sugar Fasting, Triglycerides, Complete Blood Count, Creatinine, and specialized cancer and hormone markers sold directly to individual patients and walk-in customers via website, phone, or Patient Care Centres.
- Test Profiles Bundled test panels (CBC, blood culture, urine culture, glucose tolerance, anemia, antenatal, bilirubin) sold to individual patients at panel-level pricing through the website.
- Basic Health Checkup Package Entry-level preventive health screening package covering 84 tests (blood glucose, thyroid, heart risk, liver, kidney, CBC, iron studies) sold to individual patients at a bundled discounted price of Rs 999.
- Complete Health Checkup Package Comprehensive health screening package for adults aged 20-34 covering 89 tests including diabetes, vitamins, and organ function assessments, sold to individuals at Rs 1,399.
- Male Health Package Health check-up package for males aged 35-60 covering 112 tests including diabetes monitoring, arthritis screening, vitamins profile, and infection screening, priced at Rs 2,999.
- Female Health Package Health check-up package for females above 35 years including CA125 ovarian cancer marker, LH, FSH, and prolactin testing, sold at a discounted bundle rate.
- Boys Health Package Teen boys health package (ages 13-19) covering 96 tests including vitamins profile, testosterone, and thyroid screening, priced at Rs 2,250.
- Girls Health Package Teen girls health package for ages 13-19 focusing on hormonal and lifestyle health concerns, sold at a bundled discounted rate.
- Kids Health Package Children's health check-up (ages 5-12) covering 60 tests focused on deficiencies and lifestyle disorders, sold at a discounted bundle rate of Rs 1,299.
- SARS-CoV-2 RT-PCR Test COVID-19 RT-PCR test with standard 24-hour (Rs 700) and urgent 8-hour (Rs 1,400) turnaround options, available within Delhi city limits with ICMR approval.
- Covid-19 IgG Antibody Test (CLIA) SARS-CoV-2 IgG antibody test using USFDA-approved CLIA technology per ICMR guidelines, sold to individuals seeking to assess immune response to COVID-19.
- COVID-19 Immunity Assessment Package COVID-19 immunity assessment package priced at Rs 1,499 (against a market price of Rs 3,000) with 24-hour turnaround, sold to individuals.
- COVID-19 Vitals Bio Marker Package COVID-19 vitals biomarker assessment package with 48-hour turnaround priced at Rs 1,499, sold to individuals.
- COVID-19 Advance Bio Markers Package Advanced COVID-19 biomarker testing for prognosis and severity assessment with 48-72 hour turnaround priced at Rs 1,999, sold to individuals.
- COVID-19 Comprehensive Bio Markers Package Comprehensive COVID-19 biomarker panel with next-day turnaround priced at Rs 2,999, sold to individuals.
- Home Sample Collection Service Doorstep phlebotomy service for blood, urine, and swab collection across serviceable Delhi NCR pin codes (Rs 250-350) and Bangalore (Rs 350), with non-serviceable area coverage available at Rs 2,000.
- DocCare365 Day Care Plan 24-hour day care plan priced at Rs 150 for minor procedures and monitoring, sold to individual patients.
- Corporate Health Checkup Services B2B corporate healthcare solutions including employee health check-ups, on-site medical room management, on-site health camps, pre-employment medical examinations, and pre-policy medical evaluations for insurance companies and TPAs.
- Patient Care Services Walk-in and home-based patient care services including urgent sample collection, BP monitoring, nebulization, virtual doctor consultations (general physician Rs 500, specialist Rs 800), and home healthcare services.
- National Reference Laboratory Central advanced diagnostic facility providing genetic testing, molecular diagnostics, flow cytometry, histopathology, and routine tests to clinicians, franchisees, and partner operations across India.
Quantifiable outcome
- Same-day reporting available for tests collected before 12 noon
- +4 more outcomes
Companies that use Niramaya PathLabs
Customer profileNamed customers22 records
Segments3 records
Ideal customer profiles3 records
Niramaya PathLabs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
Feature10 records
Niramaya PathLabs partnerships and signals
Strategic signalScale indicators6 records
Recent moves6 records
Expansion highlights6 records
Niramaya PathLabs competitors and assessment
Company assessmentDirect peers
- Dr. Lal PathLabs: India's largest listed diagnostic chain operating a pan-India NABL-accredited pathology network with home sample collection, preventive health packages, and corporate wellness offerings. Directly competes with Niramaya in Delhi NCR on routine and molecular testing, brand trust, and B2C/B2B segmentation.
- Thyrocare Technologies: Pan-India preventive and routine diagnostics operator with a hub-and-spoke processing model and B2B franchise network. Competes with Niramaya on preventive health packages, wellness bundles, and price-led B2C/B2B testing with national reach.
- Metropolis Healthcare: National NABL/NABL-accredited diagnostic chain offering routine and specialized testing including molecular diagnostics, histopathology, and corporate health checks. Direct overlap with Niramaya on test menu, NCR presence, and corporate wellness GTM.
- SRL Diagnostics: Agilus Diagnostics-branded pan-India diagnostic chain with extensive reference lab capabilities, hospital partnerships, and home collection. Direct competitor in NCR across routine, specialized, and corporate health testing.
- Apollo Diagnostics: The diagnostics arm of Apollo Hospitals group offering routine and specialty testing with hospital-anchored collections. Comparable to Niramaya on lab-backed preventive health packages, corporate B2B, and hospital integrated referrals.
- Neuberg Diagnostics: Multi-country diagnostic chain with strong presence in India across molecular diagnostics, genomics, and routine testing. Directly comparable on NABL-accredited reference lab, specialty testing, and Niramaya's flow cytometry / molecular diagnostics positioning.
- Suburban Diagnostics: NABL-accredited Indian diagnostic chain offering routine pathology, preventive health packages, and home sample collection. Comparable in service portfolio and B2C emphasis though more concentrated in western India.
Regional players
- Phadke Labs: Established pathology chain in Western India (Maharashtra) with home collection and preventive packages. Comparable business model and test catalog to Niramaya though geographically concentrated outside NCR.
Emerging players
- Healthians: Tech-led home diagnostics aggregator with strong digital booking and at-home sample collection across NCR and other metros. Partial overlap with Niramaya in home collection, preventive packages, and online report delivery — competitive threat on customer acquisition.
- Tata 1mg (diagnostics vertical): Digital health platform offering diagnostic test booking with home sample collection across major Indian cities. Competes with Niramaya on online-first B2C diagnostics, particularly preventive health packages and report accessibility via app.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights7 records
Customer concentration
Niramaya PathLabs social profiles
Digital presenceNiramaya PathLabs compliance and trust
Trust signalCompliance5 records
Niramaya PathLabs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Niramaya PathLabs leadership team
Management profileNumber of profiles
Profiles4 records
Niramaya PathLabs subsidiaries and ownership
Company hierarchySubsidiaries7 records
Niramaya PathLabs funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Niramaya PathLabs M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Niramaya PathLabs
What does Niramaya PathLabs do?
Niramaya PathLabs operates a NABL-accredited pathology and wellness diagnostic laboratory offering individual blood, urine and culture tests, bundled test profiles, preventive health check-up packages, COVID-19 RT-PCR and antibody testing, home sample collection across Delhi NCR, and corporate employee health check-up programs. The company's services are delivered through a central lab in New Delhi, a network of Patient Care Centres across NCR, and a phlebotomy team that performs doorstep sample collection. It also runs a National Reference Laboratory equipped with advanced molecular diagnostics, flow cytometry, and histopathology platforms.
Is Niramaya PathLabs a public or private company?
Niramaya PathLabs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Niramaya PathLabs founded?
Niramaya PathLabs was founded in 2015. It employs 11 to 50 people.
Where is Niramaya PathLabs based?
Niramaya PathLabs is headquartered in New Delhi, India, in the Asia region.
How does Niramaya PathLabs make money?
Seven revenue lines are on record. Individual Diagnostic Tests and Profiles are the primary driver. The others are health Check-up Packages, corporate Health Check-up Services, home Sample Collection Services, COVID-19 Testing and Related Services, virtual Doctor Consultations and franchise / Patient Care Center Operations.
Who are Niramaya PathLabs's main competitors?
Direct peers on record are Dr. Lal PathLabs, Thyrocare Technologies, Metropolis Healthcare, SRL Diagnostics, Apollo Diagnostics, Neuberg Diagnostics and Suburban Diagnostics. Phadke Labs is listed as a regional player. Emerging players are Healthians and Tata 1mg (diagnostics vertical).
Does Niramaya PathLabs have an API?
No public API is recorded for Niramaya PathLabs.
What industry is Niramaya PathLabs in?
Niramaya PathLabs's product category is Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR), with a secondary code of HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD). Its NAICS code is 621511 and its SIC code is 8071.